MetaCap

Myomo (MYO) vs Sensus Healthcare (SRTS)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.

Summary

Myomo (MYO) has outperformed Sensus Healthcare (SRTS) over the past year, gaining 19.5% versus a loss of 13.9%. Over five years, SRTS leads with a -25.6% price change compared with -89.4% for MYO. Myomo is the larger company by market cap ($55.9 million vs $50.0 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

MYO+19.49%SRTS-13.91%
+63%+6%-51%
Oct 8, 20251 yearOct 8, 2026
MYO-88.03%SRTS-23.06%
+307%+96%-115%
Oct 4, 20215 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

MYO versus SRTS key metrics
MetricMYOSRTS
Share price$1.41$3.04
Market cap$55.85M$50.04M
1-day change+0.01%+2.36%
YTD return+54.95%-25.38%
1-year return+19.49%-13.91%
5-year return-89.43%-25.56%
EPS (TTM)$-0.35$-0.94
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$1.89$5.49
52-week low$0.605$2.66
Distance from 52-week high-25.19%-44.63%
Analyst consensusnonenone
Avg. price target upside+229.03%+76.97%
Average volume493.94K29.46K
Shares outstanding39.61M16.46M
Employees19460
SectorHealth CareHealth Care
IndustryIndustrial SpecialtiesMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • MYO has outperformed SRTS by 33.4 percentage points over the past year.

About Myomo

MYO stock →

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living.

Health Care · Industrial Specialties · 194 employees

About Sensus Healthcare

SRTS stock →

Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide.

Health Care · Medical/Dental Instruments · 60 employees

MYO vs SRTS FAQ

Which is bigger, Myomo or Sensus Healthcare?

Myomo (MYO) is larger, with a market capitalization of $55.85M compared with $50.04M for Sensus Healthcare (SRTS).

Which stock has performed better over the past year, MYO or SRTS?

MYO returned +19.49% over the past 12 months, compared with -13.91% for SRTS (price return, excluding dividends). Past performance does not predict future results.

Are Myomo and Sensus Healthcare in the same industry?

Both are in the Health Care sector, but in different industries: Industrial Specialties for Myomo and Medical/Dental Instruments for Sensus Healthcare.

More comparisons